Comorbidity

Future Outlook for Pharmacologic Treatment of Abuse and Dependence. The importance of the psychosocial dimension ia predisposiag iadividuals toward substance use disorders and subsequentiy maintaining the disorder caimot be overestimated. Additionally, genetic influences have been found to exert an important influence on HabiUty for dmg abuse. A high comorbidity of psychiatric illnesses with substance use disorders further compHcates therapeutic iaterventions ia such patients (236). [Pg.238]

Criteria for initiation of drug treatment now take into consideration total cardiovascular risk rather than blood pressure alone, such that treatment is now recommended for persons whose blood pressure is in the normal range but still bear a heavy burden of cardiovascular risk factors. Thus, the role of simultaneous reduction of multiple cardiovascular risk factors in improving prognosis in hypertensive patients is stressed. In addition, more aggressive blood pressure goals are recommended for hypertensive patients with comorbid conditions such as diabetes mellitus or renal insufficiency. [Pg.142]

Grant BF, Harford TC Comorbidity between DSM-IV alcohol use disorders and major depression results of a national survey. Drug Alcohol Depend 39 197-206, 1995 Grant BF, Dawson DA, Stinson FS, et al The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence United States, 1991-1992 and 2001-2002. Drug Alcohol Depend 74 223-234, 2004a... [Pg.45]

Lynskey MT The comorbidity of alcohol dependence and affective disorders treatment implications. Drug Alcohol Depend 52 201-209, 1998... [Pg.49]

Sullivan LE, O Connor PC Medical disorders in substance abuse patients, in Dual Diagnosis and Psychiatric Treatment Substance Abuse and Comorbid Disorders, 2nd Edition. Edited by Kranzler HR, Tinsley JA. New York, Marcel Dekker, 2004, pp 515-553... [Pg.53]

Tollefson GD, Montague-Clouse J, Tollefson SL Treatment of comorbid generalized anxiety in a recently detoxified alcohol population with a selective serotonergic drug (buspirone). J Clin Psychopharmacol 12 19-26, 1992... [Pg.53]

A later study used DSM-III-R criteria to assess 716 opioid abusers seeking methadone maintenance treatment (Brooner et al. 1997). In evaluations conducted 1 month after admission, psychiatric comorbidity was found in 47% of... [Pg.89]

The management of comorbid medical and psychiatric conditions has become an essential component of effective opioid addiction treatment. Hepatitis C has now surpassed AIDS as the most common cause of death in... [Pg.94]

Cacciola JS, Alterman Al, Rutherford MJ, et al The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug Alcohol Depend 61 271-280, 2001... [Pg.97]

Krausz M, Degkwitz P, Kuhne A, et al Comorbidity of opiate dependence and mental disorders. Addict Behav 23 767-783, 1998... [Pg.102]

Krausz M, Verthein U, Degkwitz P Psychiatric comorbidity in opiate addicts. Eur Addict Res 5 55-62, 1999... [Pg.103]

Regier DA, Farmer ME, Rae DS, et al Comorbidity of mental disorders with alcohol and other drug abuse. JAMA 264 2511-2518, 1990 Resnick RB, Schuyten-Resnick E, Washton AM Assessment of narcotic antagonists in the treatment of opioid dependence. Annu Rev Pharmacol Toxicol 20 463-474, 1980... [Pg.106]

Roozen HG, Kerhof AJ, van den Brink W Experiences with an outpatient relapse program (community reinforcement approach) combined with naltrexone in the treatment of opioid-dependence effect on addictive behaviors and the predictive value of psychiatric comorbidity. Eur Addict Res 9 53—58, 2003 Rosen TS, Johnson HL Long-term effects of prenatal methadone maintenance. NIDA Res Monogr 59 73-83, 1985... [Pg.106]

Busto UE, Romach MK, Sellers EM Multiple drug use and psychiatric comorbidity in patients admitted to the hospital with severe benzodiazepine dependence. J Clin Psychopharmacol 16 51-57, 1996... [Pg.149]

In summary, research on the use of antidepressants to treat cannabis dependence, particularly among individuals with comorbid major depressive disorder, although limited, offers a promising avenue for the development of pharmacological aids to assist in the treatment of cannabis withdrawal. There are clear parallels between this literature and the existing research on the use of antidepressants in the treatment of alcohol dependence comorbid with major depressive disorder (see Chapter 1, Medications to Treat Co-occurring Psychiatric Symptoms or Disorders in Alcoholic Patients). [Pg.174]

Anthony JC, Warner LA, Kessler RC Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants basic findings from the National Comorbidity Survey. Exp Clin Psychopharmacol 2 244—268, 1994... [Pg.176]

Chen CY, Wagner FA, Anthony JC Marijuana use and the risk of major depressive episode epidemiological evidence from the United States National Comorbidity Survey. Soc Psychiatry Psychiatr Epidemiol 37 199-206, 2002... [Pg.176]

Grant BF Comorbidity between DSM-IV drug use disorders and major depression results of a national survey of adults. J Subst Abuse 7 481 97, 1995 Hall W, Babor TF Cannabis use and public health assessing the burden. Addiction 95 485 90, 2000... [Pg.178]

The rates of comorbid psychiatric disorders such as depression, ADHD, and antisocial personality disorder are significantly higher in stimulant abusers... [Pg.199]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...